OXFORD NANOPORE TECHNOLOGIES PL (ONT.L) Financials
ONT.L Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-06-30 | 75.9 billion | 11.8 billion |
2023-03-31 | 75.9 billion | 11.8 billion |
2022-12-31 | 82.4 billion | 13.0 billion |
2022-09-30 | 82.4 billion | 13.0 billion |
ONT.L Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-06-30 | -6.8 billion | 1.1 billion |
2023-03-31 | -3.3 billion | 1.1 billion |
2022-12-31 | -7.5 billion | 1.3 billion |
2022-09-30 | -3.3 billion | 1.3 billion |
ONT.L Net Income
No data available :(
ONT.L Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-06-30 | 37.6 billion | - | 3.3 billion |
2023-03-31 | 37.6 billion | - | - |
2022-12-31 | 47.6 billion | - | 3.4 billion |
2022-09-30 | 47.6 billion | - | - |
ONT.L Shares Outstanding
ONT.L Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-06-30 | 2.3 billion | 4.8 billion | - | - |
2023-03-31 | 700.8 million | 2.4 billion | - | - |
2022-12-31 | 2.4 billion | 4.0 billion | - | - |
2022-09-30 | 706.1 million | 2.0 billion | - | - |
ONT.L Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-06-30 | 8.6 billion | 3.6 billion |
2023-03-31 | 4.3 billion | 1.8 billion |
2022-12-31 | 7.6 billion | 3.0 billion |
2022-09-30 | 3.8 billion | 1.5 billion |
ONT.L
Price: £0.98
52 week price:
Earnings Per Share: -0.15 GBp
P/E Ratio: -10.39
Exchange: LSE
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 958.3 million